Wambolt & Associates’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.95M Sell
20,771
-1,569
-7% -$298K 1.33% 20
2025
Q1
$4.61M Sell
22,340
-1,582
-7% -$326K 1.56% 15
2024
Q4
$4.25M Sell
23,922
-5,138
-18% -$913K 1.36% 19
2024
Q3
$5.72M Buy
29,060
+565
+2% +$111K 1.56% 12
2024
Q2
$4.85M Buy
28,495
+948
+3% +$162K 1.41% 13
2024
Q1
$4.98M Buy
27,547
+97
+0.4% +$17.5K 1.49% 12
2023
Q4
$4.25M Buy
27,450
+397
+1% +$61.5K 1.39% 9
2023
Q3
$4.01M Buy
27,053
+640
+2% +$94.9K 1.46% 5
2023
Q2
$3.56M Sell
26,413
-50
-0.2% -$6.74K 1.27% 6
2023
Q1
$4.25M Buy
26,463
+579
+2% +$92.9K 1.51% 6
2022
Q4
$4.18M Buy
25,884
+386
+2% +$62.4K 1.61% 6
2022
Q3
$3.42M Buy
25,498
+97
+0.4% +$13K 1.45% 7
2022
Q2
$3.89M Buy
25,401
+742
+3% +$114K 1.56% 7
2022
Q1
$4.01M Buy
24,659
+1,522
+7% +$248K 1.46% 7
2021
Q4
$3.13M Buy
23,137
+1,074
+5% +$145K 1.13% 13
2021
Q3
$2.41M Buy
22,063
+2,055
+10% +$224K 0.97% 18
2021
Q2
$2.29M Buy
20,008
+2,346
+13% +$268K 0.97% 19
2021
Q1
$1.92M Buy
17,662
+2,697
+18% +$293K 1% 19
2020
Q4
$1.6M Buy
14,965
+2,194
+17% +$235K 0.96% 21
2020
Q3
$1.12M Buy
12,771
+2,669
+26% +$234K 0.84% 30
2020
Q2
$992K Buy
10,102
+1,860
+23% +$183K 0.78% 36
2020
Q1
$628K Buy
8,242
+2,566
+45% +$196K 0.65% 51
2019
Q4
$503K Sell
5,676
-2
-0% -$177 0.38% 85
2019
Q3
$430K Sell
5,678
-225
-4% -$17K 0.36% 97
2019
Q2
$429K Buy
5,903
+917
+18% +$66.6K 0.36% 91
2019
Q1
$412K Sell
4,986
-143
-3% -$11.8K 0.37% 87
2018
Q4
$473K Buy
+5,129
New +$473K 0.52% 61